Monographie - Dexrazoxane hydrochloride - Stabilis 4.0

Son güncelleme :
19/11/2024

Sitoprotektif

Dexrazoxane hydrochloride

Enjeksiyon

Çözeltilerin stabilitesi

Karışımlardaki stabilitesi

Stabiliteyi etkileyen faktörler

Uyumluluk

Uygulama yöntemi

Kaynaklar

pdf

Kimyasal yapı

Ticari isim

Ticari isim

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Cardioxane	Almanya, Avusturya, Brezilya, Büyük Britanya, Danimarka, Ekvador, Fransa, İrlanda, İspanya, İtalya, Macaristan, Meksika, Peru, Polonya, Şili, Venezuela
Cyrdanax	Almanya, Fransa
Dexrazoxane	Amerika Birleşik Devletleri, Ekvador
Dexrazoxano	Meksika, Peru
Razox	Peru
Razoxane	Kolombiya
Rhianta	Meksika
Savene	Almanya, Belçika, Büyük Britanya, Danimarka, Finlandiya, Fransa, Hollanda, İrlanda, İspanya, İsveç, İtalya, Macaristan, Norveç, Polonya, Romanya, Yunanistan
Zinecard	Amerika Birleşik Devletleri, Kanada
Zucordex	Meksika

Kaynaklar

Enjeksiyon

Kaynaklar : Dexrazoxane hydrochloride

	tip	yayın
381	Dergi	Beijnen JH, Van Gijn R. Chemical stability of the cardioprotective agent ICRF-187 in infusion fluids. J Parenter Sci Technol 1993 ; 47: 166-171.
1423	Dergi	Trissel LA, Martinez JF, Gilbert DL. Compatibility of gemcitabine hyrochloride with 107 selected drugs during simulated Y-site injection. J Am Pharm Assoc 1999 ; 39: 514-518.
1754	Dergi	Trissel LA, Gilbert DL, Wolkin AC. Compatibility of docetaxel with selected drugs during simulated Y-site administration. Int J Pharm Compound 1999 ; 3: 241-244.
1949	Dergi	Tetef ML, Synold TW, Chow W, Leong L, Margolin K, Morgan R, Rashko J, Shibata S, Somlo G, Yen Y, Groshen S, Johnson K, Lenz HJ, Gandara D, Doroshow JH. Phase I trial of 96 hour continuous infusion of dexrazoxane in patients with advanced malignancies. Clinical Cancer Research 2001 ; 7: 1569-1576.
1953	Dergi	Trissel LA, Saenz CA, Ogundele AB, Ingram DS. Physical compatibility of pemetrexed disodium with other drugs during simulated Y-site administration. Am J Health-Syst Pharm 2004 ; 61: 2289-2293.
2201	Dergi	Kaiser J.D, Vigneron J, Zenier H, May I, Demor? B. Chemical and physical stability of dexrazoxane, diluted with Ringer's lactate solution, in polyvinyl and polyethylene containers. EJHP Science 2007 ; 13, 3: 55-59.
2224	Dergi	Romanazzi C, Sferra S, Campi A, Rabino B, Barbieri M, Castellani S, Sabbatini L, Scanavacca P. Dexrazoxane: Stabilià in soluzione. Bolletino SIFO 2007 ; 53: 178-180.
3581	Laboratuar	Dexrazoxane (Cardioxane®) - Résumé des caractéristiques du produit Clinigen Healthcare 2013
3611	Dergi	Zhang, Y.-P, Myers, A.L., Trinh, V.A, Kawedia, J.D, Kramer, M.A, Benjamin, R.S, Tran, H.T. Physical and chemical stability of reconstituted and diluted dexrazoxane infusion solutions. J Oncol Pharm Practice 2014 ; 20, 1: 58-64.

Mentions Légales